Clinical Trials Browser

Phase 2 × Leukemia, Mast-Cell × Hydrocortisone × Clear all

NCT00186628 2017-11-28

Phase 2 Trial of Prophylactic Rituximab Therapy for Prevention of CGVHD

Phase 2 Completed

36 enrolled 12 charts

LymphoidOther hematologic neoplasm

Leukemia, Mast-Cell, Lymphoma, Mantle-Cell